Home intravenous antibiotic treatment: A study in 515 patients;Antibioterapia intravenosa en domicilio. Estudio de 515 casos

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 23, Issue 7, 2005, Pages 396-401

  Mendoza Ruiz De Zuazu, Humberto ^a   Casas Arrate, Javier ^b   Martínez Martínez, Carlos ^b   De La Maza, Itziar ^a   Regalado De Los Cobos, José ^a   Cía Ruiz, Juan Miguel ^a  

^a ACCURA UHD   (Spain)

^b HOSPITAL TXAGORRITXU   (Spain)

Author keywords

Home care service; Home therapy; Intravenous antibiotic

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEFTAZIDIME; CEFTRIAXONE; GLYCOPEPTIDE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DRUG INFUSION; EMERGENCY WARD; FEMALE; HOME CARE; HOSPITALIZATION; HUMAN; INFECTION COMPLICATION; INFUSION PUMP; MAJOR CLINICAL STUDY; MALE; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SCHOOL CHILD; URINARY TRACT INFECTION;

EID: 25844527194     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13078797     Document Type: Article

References (27)

1. Antoniskis A, Anderson BC, Van Volkinburg EJ, Jackson JM, Gilbert DN. Feasibility of outpatient self-administration of parenteral antibiotics. West J Med. 1978;128:203-6.
2. Kind AC, Williams DN, Person G, Gibson JA. Intravenous antibiotic therapy at home. Arch Intern Med. 1979;139:413-5.
3. Williams D. Home intravenous anti-infective therapy. Drug Safety. 1996; 14:1-7.
4. Hazas J, Fernández-Miera MF, Sampedro I, Dariñas MC, García de la Paz AM, Sanroma P. Antibioterapia intravenosa domiciliaria. Enferm Infecc Microbiol Clin. 1998;16:465-70.
5. Goenaga MA, Carrera JA, Garde C, Millet M. Antibióticos parenterales en el domicilio. Enferm Infecc Microbiol Clin. 1999;17:369-70.
6. Goenaga MA, Sampedro I, Garde C, Millet M, Carrera JA. Tratamientos antibióticos parenterales y Unidades de Hospitalización a Domicilio: Situación actual. Enferm Infecc Microbiol Clin. 2000;18:529.
7. Deery HG. Outpatient parenteral anti-infective therapy for skin and soft-tissue infections. Inf Dis Clin North Am. 1998;12:935-49.
8. Tice AD. Outpatient parenteral antibiotic therapy. Management for osteomyelitis. Infect Dis Clin North Am. 1998;12:903-19.
9. Bosworth DG, Nielson DW. Effectiveness of home versus hospital care in the routine treatment of cystic fibrosis. Pediatr Pulmonol. 1997;24:42-7.
10. Brown RB. Outpatient parenteral antibiotic therapy in the management of community-acquired lower respiratory infections. Infect Dis Clin North Am. 1998;12:921-33.
11. Goodfellow A, O Wai A, Frighetto L, Marra C, Ferreira B, Lynn Chase M, et al. Quality of life assessment in an outpatient parenteral antibiotic program. Ann Pharmacother. 2002;36:1851-5.
12. Chamberlain T, Lehman M, Groh M, Munroe W, Reinders T. Cost analysis of a home intravenous antibiotic program. Am J Hosp Pharm. 1988;45:2341-5.
13. Tice AD, Nolet BR. Delivery models for outpatient parenteral antimicrobial therapy. En: Outpatient parenteral antimicrobial therapy: current status. Scientific American Medicine. New York: Scientific American; 1997. p. 7-11.
14. Williams D, Raymond J. Practice guidelines for community-based parenteral anti-infective therapy. Infect Dis Clin North Am. 1998;12:1009-21.
15. Tice AD. Outpatient parenteral antibiotic therapy (OPAT) in the United States: delivery models and indications for use. Can J Infect Dis. 2000;11: 17-21.
16. Huminer D, Bishara J, Pitlik S. Home intravenous antibiotic therapy for patients with infective endocarditis. Eur J Clin Microbiol Infect Dis. 1999;18: 330-4.
17. Atlas SJ, Benzer TI, Borowsky LH, Chang Y, Burnham DC, Metlay JP, et al. Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial. Arch Intern Med. 1998;158:1350-6.
18. Safrin S, Siegel D, Black D. Pyelonephritis in adult women: Inpatient versus outpatient therapy. Am J Med. 1988;85:793.
19. Escalante CP, Rubenstein EB, Rolston KV. Outpatient antibiotic therapy for febrile episodes in low-risk neutropenic patients with cancer. Drugs Pharm. 1997;15:237-42.
20. Gilbert D, Dworkin R, Raber S, Leggett J. Outpatient parenteral antimicrobial-drug therapy. N Engl J Med. 1997;4:829-38.
21. Auble T, Yealy D, Fine M. Assessing prognosis and selecting an initial site of care for adults with community-acquired pneumonia. Inf Dis Clin Norh Am. 1998;12:741-59.
22. Guglielmo BJ, Luber AD, Paletta D, Jacobs RA. Ceftriaxone therapy for staphylococcal osteomyelitis: a review. Clin Infect Dis. 2000;30:205-7.
23. Kaplinsky C, Drucker M, Goshen J, Tamary H, Cohen IJ, Zaizov R. Ambulatory treatment with ceftriaxone in febrile neutropenic children. Isr J Med Sci. 1994;30:649-51.
24. Goenaga MA, Garde C, Millet M, Arzelus E. Reingresos hospitalarios en pacientes tratados con antibióticos parenterales en domicilio. Med Clin (Barc). 2003;121:595-6.
25. Goenaga MA, Garde C, Millet M, Carrera JA. Tratamientos antimicrobianos parenterales en domicilio. Experiencia de 5 años. Rev Clin Esp. 2002;202: 142-7.
26. Balfour JAB, Lamb HM. Outpatient parenteral antibacterial therapy of serious infections: the role of ceftriaxone. Dis Manage Health Ourtcomes. 1998;4:225-36.
27. Rehm SJ, McCafferty B, Carroll D, Taege AJ Longworth DL. Hospital re-admissions among patients receiving community-based parenteral anti-infective therapy (CoPAT). 37th Annual IDSA 1999 November 18-21:Philadelphia. Clin Infect Dis. 1999;29:1054 [Abstract 529].